The New York Times, August 2, 2013

In late June news organizations reported on a practical application in the United States of "reference pricing" for hospital care. The concept has been well known for decades to health policy wonks and already applied to prescription drugs in many other countries, but it is still novel in the United States. In the arsenal now being assembled on the payment side of health care to address rising costs, reference pricing may well turn out to be the sleeper, because it is a potentially powerful method of "putting the patient's skin in the game," the delicate phrase we use for "cost-sharing by patients."
Facebook icon
LinkedIn icon
Twitter icon